Tag archive for ‘Insulin’
Insulin diabetes- Health technology blood test 777001_640
Lily Bethlehem On Thursday, November 26th, 2020

Oramed Pharmaceuticals Advancing With an Oral Insulin

    Israel’s Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. It is moving forward with More...

Jewish Business News On Tuesday, September 8th, 2015

Fatty liver? Be Activ!

You might not know if you are among the approximately 30 percent of the population suffering from fatty liver disease, the most common liver condition in the Western world. It usually causes no symptoms aside More...

Israeli Oramed to raise $50 million from two Chinese investors

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP),  has signed a non-binding Letter of Intent (LoI) for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science More...

Jewish Business News On Tuesday, June 16th, 2015

Israel’s Oramed Granted Patent in Russia for Oral Administration of GLP-1

– – Israeli startup Oramed Pharmaceuticals, a developer of oral drug delivery systems, has been granted by the Russian Federal Service for Intellectual Property a patent for its invention,  More...

Gil Tanenbaum On Friday, February 20th, 2015

Beta-O2’s ßAir Bio-artificial Adrenal Device Shows Potential to Treat Stress-related Disorders

Israeli biomedical firm Beta-O2 announced the results of a series of pre-clinical studies demonstrating that the company’s ßAir Bio-artificial Adrenal device could offer a treatment for adrenocortical More...

Jewish Business News Service On Thursday, October 31st, 2013

Kamada : New Data from an Extension Study Trial with Glassia in Pediatric Patients with Type 1 Diabetes

– Kamada plans to initiate a Phase II/III trial with Glassia with newly diagnosed type one diabetes pediatric and young adult patients. – – Kamada Ltd. (Nasdaq: KMDA); TASE: KMDA) has More...

Gali Weinreb On Thursday, October 17th, 2013

Insuline Signs J&J Marketing Deal For A Pilot In Germany

– Insuline has developed a medical device that increases insulin absorption. – – Insuline Medical Ltd. (TASE: INSL), developer of a medical device that improves the rate of insulin More...

Wordpress site Developed by Fixing WordPress Problems